ArticleScientific reports2026
Machine learning-based risk stratification of early graft failure in simultaneous pancreas-kidney transplantation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simultaneous pancreas–kidney transplantation (SPK) restores insulin independence for patients with diabetes and end-stage renal disease, yet early graft failure remains a major obstacle. We analyzed 6,725 adult SPK procedures recorded by UNOS between 2014 and 2024 to build a peri-operative risk model using Random Survival Forests (RSF). After preprocessing, MissForest imputation and LASSO screening, 21 predictors were retained. The RSF, trained on 80% of the data and tested on the remainder, achieved a Harrell C-index of 0.73 and a Uno C-index of 0.58; time-dependent AUCs were 0.75 and 0.74 at one and two years, with Brier scores of 0.075 and 0.090. Maximizing Youden’s J produced a risk-score threshold of 105.24 that separated recipients into high- and low-risk strata with strongly divergent Kaplan–Meier curves (log-rank p = 2.4e−16). Decision-curve analysis demonstrated net clinical benefit across threshold probabilities 0–0.25 and, at a 10% threshold, predicted 41 unnecessary interventions avoided per 100 patients relative to treating all. Pre-transplant insulin status, cold-ischemia time and recipient age dominated variable importance. A compact RSF based on routinely collected peri-operative data provided internally validated graft-failure risk stratification that may support peri-operative risk assessment and targeted surveillance. Prospective multi-center validation is required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.